Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.

Hallakou-Bozec S, Kergoat M, Fouqueray P, Bolze S, Moller DE

Open source

DOI
10.1371/journal.pone.0241651
Published
2021
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0241651,
  title = {Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.},
  author = {Hallakou-Bozec S and Kergoat M and Fouqueray P and Bolze S and Moller DE},
  year = {2021},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0241651},
  url = {https://doi.org/10.1371/journal.pone.0241651}
}

RIS

TY  - JOUR
TI  - Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.
AU  - Hallakou-Bozec S
AU  - Kergoat M
AU  - Fouqueray P
AU  - Bolze S
AU  - Moller DE
PY  - 2021
JO  - PloS one
DO  - 10.1371/journal.pone.0241651
UR  - https://doi.org/10.1371/journal.pone.0241651
ER  - 

APA

S, H., M, K., P, F., S, B., & DE, M. (2021). Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.. PloS one. https://doi.org/10.1371/journal.pone.0241651

Source records